Title |
Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
|
---|---|
Published in |
Cancer Cell International, July 2013
|
DOI | 10.1186/1475-2867-13-77 |
Pubmed ID | |
Authors |
Xueqing Wang, Lingya Pan, Ning Mao, Lifang Sun, Xiangjuan Qin, Jie Yin |
Abstract |
Taxol is a powerful chemotherapy agent leading to mitotic arrest and cell death; however, its clinical efficacy has been hampered due to the development of drug resistance. Taxol specifically targets the cell cycle. Progress through mitosis (M stage) is an absolute requirement for drug-induced death because cell death is markedly reduced in cells blocked at the G1-S transition. The measured doubling time for ovarian cancer cells is about 27 h. As such, during treatment with Taxol most of the cells are not in the M stage of the cell cycle. Thus, the effect of cell-cycle synchronization was investigated in regard to reversing Taxol resistance in ovarian cancer cells. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 44 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 22% |
Researcher | 7 | 16% |
Student > Bachelor | 7 | 16% |
Student > Doctoral Student | 4 | 9% |
Student > Postgraduate | 3 | 7% |
Other | 8 | 18% |
Unknown | 6 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 27% |
Biochemistry, Genetics and Molecular Biology | 12 | 27% |
Medicine and Dentistry | 6 | 13% |
Engineering | 2 | 4% |
Environmental Science | 1 | 2% |
Other | 4 | 9% |
Unknown | 8 | 18% |